Time-dependent miR-16 serum fluctuations together with reciprocal changes in the expression level of miR-16 in mesocortical circuit contribute to stress resilient phenotype in chronic mild stress - An animal model of depression

European Neuropsychopharmacology

Volumn 26, Issue 1, 2016, Pages 23-36

  Zurawek, Dariusz ^a   Kusmider, Maciej ^a   Faron Gorecka, Agata ^a   Gruca, Piotr ^a   Pabian, Paulina ^a   Kolasa, Magdalena ^a   Solich, Joanna ^a   Szafran Pilch, Kinga ^a   Papp, Mariusz ^a   Dziedzicka Wasylewska, Marta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Biomarker; Chronic mild stress; Depression; MicroRNA; Rats; Stress resilience

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTERONE; MELATONIN; MICRORNA; MICRORNA 16; MIRN16 MICRORNA, RAT; SUGAR INTAKE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BRAIN REGION; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; GENE CONTROL; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC CORTEX; MALE; NERVOUS SYSTEM FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SUCROSE PREFERENCE TEST; TIME; ANIMAL; BLOOD; CHRONIC DISEASE; DISEASE MODEL; FEEDING BEHAVIOR; LIMBIC SYSTEM; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL RESILIENCE; RANDOMIZATION; SUGAR INTAKE; WISTAR RAT;

ANHEDONIA; ANIMALS; BIOMARKERS; CHRONIC DISEASE; CORTICOSTERONE; DEPRESSIVE DISORDER; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; LIMBIC SYSTEM; MALE; MELATONIN; MICRORNAS; RANDOM ALLOCATION; RATS, WISTAR; RESILIENCE, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL; TIME;

EID: 84959171335     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.11.013     Document Type: Article

References (54)

1. Andreasen D., Fog J.U., Biggs W., Salomon J., Dahslveen I.K., Baker A., Mouritzen P. Improved microRNA quantification in total RNA from clinical samples. Methods 2010, 50(4):S6-S9.
2. Azpiroz A., Fano E., Garmendia L., Arregi A., Cacho R., Beitia G., Brain P.F. Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice. Psychoneuroendocrinology 1999, 24(3):345-361.
3. Bai M., Zhu X., Zhang Y., Zhang S., Zhang L., Xue L., Yi J., Yao S., Zhang X. Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PloS One 2012, 7(10):e46921.
4. Baudry A., Mouillet-Richard S., Schneider B., Launay J.M., Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010, 329(5998):1537-1541.
5. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57:289-300.
6. Blugeot A., Rivat C., Bouvier E., Molet J., Mouchard A., Zeau B., Bernard C., Benoliel J.J., Becker C. Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J. Neurosci. 2011, 31(36):12889-12899.
7. Bocchio-Chiavetto L., Maffioletti E., Bettinsoli P., Giovannini C., Bignotti S., Tardito D., Corrada D., Milanesi L., Gennarelli M. Blood microRNA changes in depressed patients during antidepressant treatment. Eur. Neuropsychopharmacol. 2013, 23(7):602-611.
8. Carmona-Saez P., Chagoyen M., Tirado F., Carazo J.M., Pascual-Montano A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 2007, 8(1):R3.
9. Charney D.S. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 2004, 161(2):195-216.
10. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C.Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18(10):997-1006.
11. Chen Y., Gelfond J.A., McManus L.M., Shireman P.K. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genom. 2009, 10:407.
12. Christiansen S., Bouzinova E.V., Palme R., Wiborg O. Circadian activity of the hypothalamic-pituitary-adrenal axis is differentially affected in the rat chronic mild stress model of depression. Stress 2012, 15(6):647-657.
13. Cohen H., Zohar J., Gidron Y., Matar M.A., Belkind D., Loewenthal U., Kozlovsky N., Kaplan Z. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol. Psychiatry 2006, 59(12):1208-1218.
14. Corrada D., Viti F., Merelli I., Battaglia C., Milanesi L. myMIR: a genome-wide microRNA targets identification and annotation tool. Brief Bioinf. 2011, 12(6):588-600.
15. Dweep H., Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat. Methods 2015, 12(8):697.
16. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk - database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inf. 2011, 44(5):839-847.
17. Dwivedi Y. Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications. Dialogues Clin. Neurosci. 2014, 16(1):43-61.
18. Feder A., Nestler E.J., Charney D.S. Psychobiology and molecular genetics of resilience. Nat. Rev. Neurosci. 2009, 10(6):446-457.
19. Haglund M.E., Nestadt P.S., Cooper N.S., Southwick S.M., Charney D.S. Psychobiological mechanisms of resilience: relevance to prevention and treatment of stress-related psychopathology. Dev. Psychopathol. 2007, 19(3):889-920.
20. Hansen M.V., Danielsen A.K., Hageman I., Rosenberg J., Gögenur I. The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: a systematic review and meta-analysis. Eur. Neuropsychopharmacol. 2014, 24(11):1719-1728.
21. Haramati S., Navon I., Issler O., Ezra-Nevo G., Gil S., Zwang R., Hornstein E., Chen A. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J. Neurosci. 2011, 31(40):14191-14203.
22. Higa G.S., de Sousa E., Walter L.T., Kinjo E.R., Resende R.R., Kihara A.H. MicroRNAs in neuronal communication. Mol. Neurobiol. 2014, 49(3):1309-1326.
23. Honda M., Kuwano Y., Katsuura-Kamano S., Kamezaki Y., Fujita K., Akaike Y., Kano S., Nishida K., Masuda K., Rokutan K. Chronic academic stress increases a group of microRNAs in peripheral blood. PloS One 2013, 8(10):e75960.
24. Issler O., Haramati S., Paul E.D., Maeno H., Navon I., Zwang R., Gil S., Mayberg H.S., Dunlop B.W., Menke A., Awatramani R., Binder E.B., Deneris E.S., Lowry C.A., Chen A. MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron 16 2014, 83(2):344-360.
25. Jin X.F., Wu N., Wang L., Li J. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell. Mol. Neurobiol. 2013, 33(5):601-613.
26. de Kloet E.R., Joëls M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6(6):463-475.
27. Kozomara A., Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014, 42:D68-D73.
28. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131(2):391-404.
29. Launay J.M., Mouillet-Richard S., Baudry A., Pietri M., Kellermann O. Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl. Psychiatry 2011, 1:e56.
30. Li Y.J., Xu M., Gao Z.H., Wang Y.Q., Yue Z., Zhang Y.X., Li X.X., Zhang C., Xie S.Y., Wang P.Y. Alterations of serum levels of BDNF-related miRNAs in patients with depression. PloS One 2013, 8(5):e63648.
31. Liu B.B., Luo L., Liu X.L., Geng D., Liu Q., Yi L.T. 7-Chlorokynurenic acid (7-CTKA) produces rapid antidepressant-like effects: through regulating hippocampal microRNA expressions involved in TrkB-ERK/Akt signaling pathways in mice exposed to chronic unpredictable mild stress. Psychopharmacology 2015, 232(3):541-550.
32. Liu Y., Zhang J., Han R., Liu H., Sun D., Liu X. Downregulation of serum brain specific microRNA is associated with inflammation and infarct volume in acute ischemic stroke. J. Clin. Neurosci. 2015, 22(2):291-295.
33. Lopez J.P., Lim R., Cruceanu C., Crapper L., Fasano C., Labonte B., Maussion G., Yang J.P., Yerko V., Vigneault E., El Mestikawy S., Mechawar N., Pavlidis P., Turecki G. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat. Med. 2014, 20(7):764-768.
34. McClung C.A. Circadian rhythms and mood regulation: insights from pre-clinical models. Eur. Neuropsychopharmacol. 2011, 21(Suppl 4):S683-S693.
35. McEwen B.S., Gray J., Nasca C. Recognizing Resilience: Learning from the Effects of Stress on the Brain. Neurobiol. Stress 2015, 1:1-11.
36. Meerson A., Cacheaux L., Goosens K.A., Sapolsky R.M., Soreq H., Kaufer D. Changes in brain MicroRNAs contribute to cholinergic stress reactions. J. Mol. Neurosci. 2010, 40(1-2):47-55.
37. Mestdagh P., Van Vlierberghe P., De Weer A., Muth D., Westermann F., Speleman F., Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009, 10(6):R64.
38. Moreau M.P., Bruse S.E., David-Rus R., Buyske S., Brzustowicz L.M. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 2011, 69(2):188-193.
39. Mouillet-Richard S., Baudry A., Launay J.M., Kellermann O. MicroRNAs and depression. Neurobiol. Dis. 2012, 46(2):272-278.
40. O'Connor R.M., Grenham S., Dinan T.G., Cryan J.F. microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int. J. Neuropsychopharmacol. 2013, 16(8):1885-1892.
41. Qureshi R., Sacan A. A novel method for the normalization of microRNA RT-PCR data. BMC Med. Genom. 2013, 6(Suppl 1):S14.
42. Rinaldi A., Vincenti S., De Vito F., Bozzoni I., Oliverio A., Presutti C., Fragapane P., Mele A. Stress induces region specific alterations in microRNAs expression in mice. Behav. Brain Res. 2010, 208(1):265-269.
43. Rong H., Liu T.B., Yang K.J., Yang H.C., Wu D.H., Liao C.P., Hong F., Yang H.Z., Wan F., Ye X.Y., Xu D., Zhang X., Chao C.A., Shen Q.J. MicroRNA-134 plasma levels before and after treatment for bipolar mania. J. Psychiatr. Res. 2011, 45(1):92-95.
44. Santarelli D.M., Liu B., Duncan C.E., Beveridge N.J., Tooney P.A., Schofield P.R., Cairns M.J. Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine. Psychopharmacology 2013, 227(1):67-78.
45. Schumann G., Binder E.B., Holte A., de Kloet E.R., Oedegaard K.J., Robbins T.W., Walker-Tilley T.R., Bitter I., Brown V.J., Buitelaar J., Ciccocioppo R., Cools R., Escera C., Fleischhacker W., Flor H., Frith C.D., Heinz A., Johnsen E., Kirschbaum C., Klingberg T., Lesch K.P., Lewis S., Maier W., Mann K., Martinot J.L., Meyer-Lindenberg A., Müller C.P., Müller W.E., Nutt D.J., Persico A., Perugi G., Pessiglione M., Preuss U.W., Roiser J.P., Rossini P.M., Rybakowski J.K., Sandi C., Stephan K.E., Undurraga J., Vieta E., van der Wee N., Wykes T., Haro J.M., Wittchen H.U. Stratified medicine for mental disorders. Eur. Neuropsychopharmacol. 2014, 24(1):5-50.
46. Singh M., Jadhav H.R. Melatonin: functions and ligands. Drug. Discov. Today 2014, 19(9):1410-1418.
47. Smalheiser N.R., Lugli G., Rizavi H.S., Torvik V.I., Turecki G., Dwivedi Y. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PloS One 2012, 7(3):e33201.
48. Smalheiser N.R., Lugli G., Zhang H., Rizavi H., Cook E.H., Dwivedi Y. Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia., bipolar disorder and depressed subjects. PloS One 2014, 9(1):e86469.
49. Smalheiser N.R., Lugli G., Rizavi H.S., Zhang H., Torvik V.I., Pandey G.N., Davis J.M., Dwivedi Y. MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int. J. Neuropsychopharmacol. 2011, 14(10):1315-1325.
50. Tabas-Madrid D., Nogales-Cadenas R., Pascual-Montano A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 2012, 40:W478-W483.
51. Taliaz D., Loya A., Gersner R., Haramati S., Chen A., Zangen A. Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J. Neurosci. 2011, 31(12):4475-4483.
52. Wiborg O. Chronic mild stress for modeling anhedonia. Cell. Tissue Res. 2013, 354(1):155-169.
53. Zurawek D., Faron-Górecka A., Kuśmider M., Kolasa M., Gruca P., Papp M., Dziedzicka-Wasylewska M. Mesolimbic dopamine D receptor plasticity contributes to stress resilience in rats subjected to chronic mild stress. Psychopharmacology 2013, 227(4):583-593.
54. Zurawek D., Faron-Gorecka A., Kusmider M., Solich J., Kolasa M., Szafran-Pilch K., Kmiotek K., Gruca P., Papp M., Dziedzicka-Wasylewska M. Dopamine D1 and D2 receptors in chronic mild stress: analysis of dynamic receptor changes in an animal model of depression using in situ hybridization and autoradiography. Dopamine Receptor Technologies., Neuromethods 2015, 96:355-375. Springer Science+Business Media, New York.